- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有509家主力机构披露2025-06-30报告期持股数据，持仓量总计8.96亿股，占流通A股80.37%
- 波段诊断：
-
技术面诊股
诊断结果：6.5技术面打败了43%的股票
技术面评分前10的股票
近期的平均成本为53.73元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为53.73元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"53.73","date":1761120026,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，明显跑输行业平均水平。
[{"date":"2025.10.23","stock":"-1.27","trade":"-1.12","ind":"0.22"},{"date":"2025.10.22","stock":"-2.12","trade":"0.67","ind":"-0.62"},{"date":"2025.10.21","stock":"0.66","trade":"1.33","ind":"2.06"},{"date":"2025.10.20","stock":"-1.71","trade":"0.37","ind":"0.98"},{"date":"2025.10.17","stock":"0.51","trade":"-1.01","ind":"-3.04"},{"date":"2025.10.16","stock":"3.09","trade":"0.19","ind":"-0.25"},{"date":"2025.10.15","stock":"2.63","trade":"2.81","ind":"1.73"},{"date":"2025.10.14","stock":"-3.42","trade":"-1.22","ind":"-2.54"},{"date":"2025.10.13","stock":"-1.94","trade":"-0.84","ind":"-0.93"},{"date":"2025.10.10","stock":"-2.86","trade":"-0.24","ind":"-2.70"},{"date":"2025.10.09","stock":"-3.96","trade":"-0.39","ind":"1.47"},{"date":"2025.09.30","stock":"1.67","trade":"0.72","ind":"0.35"},{"date":"2025.09.29","stock":"-2.14","trade":"-0.14","ind":"2.05"},{"date":"2025.09.26","stock":"-2.63","trade":"-1.67","ind":"-1.76"},{"date":"2025.09.25","stock":"3.42","trade":"-0.91","ind":"0.67"},{"date":"2025.09.24","stock":"10.01","trade":"1.94","ind":"1.80"},{"date":"2025.09.23","stock":"5.55","trade":"-1.95","ind":"-0.29"},{"date":"2025.09.22","stock":"-0.95","trade":"-0.40","ind":"0.67"},{"date":"2025.09.19","stock":"-3.89","trade":"-1.50","ind":"-0.04"},{"date":"2025.09.18","stock":"3.59","trade":"-0.61","ind":"-1.06"},{"date":"2025.09.17","stock":"-0.23","trade":"-0.67","ind":"1.16"}]
信立泰,深证成指,化学制药指数
压力支撑
该股压力位为53.78元，支撑位为52.52元。
[{"text":"\u538b\u529b\u4f4d","value":"53.78","date":1761148800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"52.52","date":1761148800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.3资金面打败了66%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月23日 20:31
| 机构今日流向(万元) | -2895.77 | 机构5日流向(万元) | -5967.33 |
| 机构10日流向(万元) | -11616.09 | 机构20日流向(万元) | -22833.82 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加4116.57万股，其中基金净减仓86家，主力净增仓173家，请投资者中长期谨慎为宜。
截止2025-06-30，共509家主力机构（基金502家，一般法人5家，社保基金1家，券商集合理财1家），持仓量总计89582.38万股，占流通A股80.37%
其中，基金持仓与2024-12-31相比：
增仓：60家 ，增持 2337.44万股
减仓：146家 ，减持 1775.87万股
新出现在主力名单中：287家 ，持有6191.84万股
从主力名单中消失：114家 ，原持有2478.39万股
其中，基金持仓与2024-12-31相比：
增仓：60家 ，增持 2337.44万股
减仓：146家 ，减持 1775.87万股
新出现在主力名单中：287家 ，持有6191.84万股
从主力名单中消失：114家 ，原持有2478.39万股
消息面诊股
诊断结果：6.1消息面打败了83%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 信立泰：10月22日获融资买入2661.45万元
2025-10-23 - 创新药调整到位、信达百亿美金大BD催化，持续看好行
2025-10-22 - 信立泰：10月21日持仓该股ETF资金净流出336
2025-10-22 - 信立泰：10月21日获融资买入1707.31万元
2025-10-22 - 抗癌新药JK06临床试验获突破，信立泰在晚期实体瘤
2025-10-21 - 信立泰：10月20日持仓该股ETF资金净流入367
2025-10-21 - 信立泰：10月20日获融资买入1969.08万元
2025-10-21 - 近一个月这些上市公司被“踏破门槛”！固态电池概念股
2025-10-20 - 信立泰：10月17日获融资买入3260.57万元
2025-10-20 - 一天5笔BD点燃市场！“小恒瑞”却市值触底，第2梯
2025-10-17
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-20 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-08-20 |
| 一般消息 | 募资投向 | 2025-08-19 | |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-06-24 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-06-24 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-03-29 |
| 利好 | 分红转增 | 10派5元(含税) | 2025-03-29 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.0行业面打败了79%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2025.10.23","price":"0.22","value":"-1.12"},{"date":"2025.10.22","price":"-0.62","value":"0.67"},{"date":"2025.10.21","price":"2.06","value":"1.33"},{"date":"2025.10.20","price":"0.98","value":"0.37"},{"date":"2025.10.17","price":"-3.04","value":"-1.01"},{"date":"2025.10.16","price":"-0.25","value":"0.19"},{"date":"2025.10.15","price":"1.73","value":"2.81"},{"date":"2025.10.14","price":"-2.54","value":"-1.22"},{"date":"2025.10.13","price":"-0.93","value":"-0.84"},{"date":"2025.10.10","price":"-2.70","value":"-0.24"},{"date":"2025.10.09","price":"1.47","value":"-0.39"},{"date":"2025.09.30","price":"0.35","value":"0.72"},{"date":"2025.09.29","price":"2.05","value":"-0.14"},{"date":"2025.09.26","price":"-1.76","value":"-1.67"},{"date":"2025.09.25","price":"0.67","value":"-0.91"},{"date":"2025.09.24","price":"1.80","value":"1.94"},{"date":"2025.09.23","price":"-0.29","value":"-1.95"},{"date":"2025.09.22","price":"0.67","value":"-0.40"},{"date":"2025.09.19","price":"-0.04","value":"-1.50"},{"date":"2025.09.18","price":"-1.06","value":"-0.61"},{"date":"2025.09.17","price":"1.16","value":"-0.67"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 向日葵 | 77.92% | -10.44% | 5.1分 |
| 2 | 多瑞医药 | 29.22% | 9.69% | 6.6分 |
| 3 | *ST景峰 | 19.76% | 17.54% | 5.3分 |
| 4 | 广济药业 | 18.84% | 21.82% | 5.9分 |
| 5 | 亚太药业 | 18.40% | -3.71% | 6.0分 |
| 6 | 金石亚药 | 16.75% | 16.40% | 6.5分 |
| 8 | 亨迪药业 | 13.58% | 18.77% | 6.0分 |
| 10 | 康芝药业 | 10.35% | -0.53% | 5.8分 |
| 12 | *ST苏吴 | 8.60% | 1.00% | 5.2分 |
| 14 | 赛分科技 | 5.74% | 3.92% | 6.7分 |
| 16 | 广生堂 | 3.11% | -9.46% | 5.3分 |
| 18 | 哈三联 | 2.99% | 5.06% | 5.4分 |
| 20 | 山河药辅 | 2.61% | 3.23% | 5.4分 |
| 22 | 联环药业 | 2.18% | -1.22% | 5.8分 |
| 24 | 双鹭药业 | 1.74% | 3.39% | 6.4分 |
| 26 | 华北制药 | 1.50% | 2.18% | 6.7分 |
| 28 | 丰原药业 | 1.34% | 2.72% | 6.4分 |
| 30 | 汉商集团 | 1.12% | 3.43% | 6.7分 |
| 32 | 罗欣药业 | 1.10% | -0.72% | 6.1分 |
| 34 | 莱美药业 | 0.87% | -3.75% | 5.9分 |
| 36 | 西点药业 | 0.29% | 3.06% | 6.3分 |
| 38 | 富士莱 | 0.25% | 4.66% | 6.4分 |
| 40 | 天新药业 | 0.15% | 0.22% | 6.2分 |
| 42 | 东亚药业 | 0.00% | 3.96% | 6.1分 |
| 44 | 河化股份 | -0.39% | 4.81% | 7.1分 |
| 46 | 奥锐特 | -0.66% | 1.44% | 6.2分 |
| 48 | 仟源医药 | -1.10% | -1.10% | 6.1分 |
| 50 | 海正药业 | -1.32% | 0.19% | 6.2分 |
| 52 | 卫信康 | -1.48% | 1.52% | 6.7分 |
| 54 | 易明医药 | -1.80% | 1.93% | 5.5分 |
| 56 | 国邦医药 | -2.24% | -5.91% | 5.5分 |
| 58 | 本立科技 | -2.50% | 1.17% | 6.2分 |
| 60 | 海森药业 | -2.58% | 0.83% | 5.9分 |
| 62 | 圣诺生物 | -2.71% | -1.34% | 6.2分 |
| 64 | 宣泰医药 | -2.96% | 1.60% | 6.3分 |
| 66 | 永安药业 | -3.15% | -6.95% | 3.9分 |
| 68 | 神奇制药 | -3.26% | 3.16% | 6.6分 |
| 70 | 福安药业 | -3.48% | 0.68% | 5.9分 |
| 72 | - | -3.78% | 1.91% | 分 |
| 74 | 川宁生物 | -3.93% | 0.00% | 5.3分 |
| 76 | 仙琚制药 | -4.08% | -0.92% | 5.8分 |
| 78 | 九典制药 | -4.26% | -1.52% | 5.2分 |
| 80 | 泽璟制药 | -4.62% | -2.38% | 5.4分 |
| 82 | 浙江医药 | -4.71% | -0.35% | 5.7分 |
| 84 | 同和药业 | -4.73% | 2.85% | 6.2分 |
| 86 | - | -4.93% | 1.48% | 分 |
| 88 | 前沿生物 | -5.03% | -3.35% | 4.8分 |
| 90 | 威尔药业 | -5.31% | 0.22% | 6.3分 |
| 92 | 科伦药业 | -5.46% | 0.14% | 5.4分 |
| 94 | - | -5.66% | 2.04% | 分 |
| 96 | 上海谊众 | -5.72% | -3.02% | 5.2分 |
| 98 | 海普瑞 | -5.77% | 1.19% | 6.5分 |
| 100 | 丽珠集团 | -6.15% | -1.35% | 5.8分 |
| 102 | 复旦张江 | -6.50% | -0.66% | 5.5分 |
| 104 | 恒瑞医药 | -7.12% | -2.54% | 6.1分 |
| 106 | 富祥药业 | -7.40% | 2.60% | 5.3分 |
| 108 | 科源制药 | -7.51% | -1.22% | 5.3分 |
| 110 | - | -7.64% | 0.36% | 分 |
| 112 | *ST赛隆 | -7.82% | 5.12% | 5.4分 |
| 114 | 海思科 | -8.18% | -3.09% | 6.5分 |
| 116 | 润都股份 | -8.67% | -4.00% | 5.3分 |
| 118 | 京新药业 | -9.20% | -1.41% | 5.0分 |
| 120 | 复星医药 | -9.27% | -0.96% | 5.3分 |
| 122 | 小方制药 | -9.35% | -2.93% | 5.3分 |
| 124 | 花园生物 | -9.39% | -4.86% | 5.1分 |
| 126 | - | -9.62% | 0.15% | 分 |
| 128 | 海翔药业 | -9.84% | 1.05% | 5.4分 |
| 130 | 奥翔药业 | -9.90% | -1.08% | 5.6分 |
| 132 | 亿帆医药 | -10.69% | -7.37% | 5.3分 |
| 134 | ST诺泰 | -11.68% | 5.50% | 5.3分 |
| 136 | 百济神州 | -11.80% | -3.27% | 5.2分 |
| 138 | 翰宇药业 | -11.96% | -2.16% | 5.7分 |
| 140 | 微芯生物 | -12.62% | -4.46% | 5.6分 |
| 142 | 亚虹医药 | -13.20% | -1.99% | 5.1分 |
| 144 | 悦康药业 | -13.32% | -3.04% | 5.4分 |
| 146 | 金城医药 | -14.42% | -2.32% | 5.2分 |
| 148 | 迪哲医药 | -17.65% | -9.38% | 5.5分 |
| 150 | 海辰药业 | -18.36% | -11.38% | 4.2分 |
| 152 | 新诺威 | -18.87% | -10.24% | 5.2分 |
| 154 | 益方生物 | -24.39% | -5.37% | 5.1分 |
| 156 | 南新制药 | -35.07% | 3.68% | 4.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 54/219 ， 23/219。
[{"date":"2025-06-30","value":"4.23","vol":"1.21"},{"date":"2025-03-31","value":"2.27","vol":"-0.17"},{"date":"2024-12-31","value":"7.19","vol":"19.51"},{"date":"2024-09-30","value":"6.13","vol":"4.61"},{"date":"2024-06-30","value":"4.34","vol":"3.52"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.23 | 2.27 | 7.19 | 6.13 | 4.34 |
| 行业(%) | 1.21 | -0.17 | 19.51 | 4.61 | 3.52 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"75.31","vol":"49.43"},{"date":"2025-03-31","value":"75.32","vol":"49.23"},{"date":"2024-12-31","value":"72.64","vol":"50.77"},{"date":"2024-09-30","value":"72.07","vol":"50.51"},{"date":"2024-06-30","value":"71.13","vol":"50.51"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
75.31 | 75.32 | 72.64 | 72.07 | 71.13 |
| 行业(%) | 49.43 | 49.23 | 50.77 | 50.51 | 50.51 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 47/219 ， 65/219。
[{"date":"2025-06-30","value":"4.32","vol":"78.53"},{"date":"2025-03-31","value":"-2.64","vol":"-0.84"},{"date":"2024-12-31","value":"19.22","vol":"17.76"},{"date":"2024-09-30","value":"22.18","vol":"45.69"},{"date":"2024-06-30","value":"21.28","vol":"705.61"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
4.32 | -2.64 | 19.22 | 22.18 | 21.28 |
| 行业(%) | 78.53 | -0.84 | 17.76 | 45.69 | 705.61 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"6.10","vol":"56.29"},{"date":"2025-03-31","value":"0.03","vol":"-21.21"},{"date":"2024-12-31","value":"3.71","vol":"-20.55"},{"date":"2024-09-30","value":"6.37","vol":"-32.33"},{"date":"2024-06-30","value":"1.92","vol":"8.09"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
6.10 | 0.03 | 3.71 | 6.37 | 1.92 |
| 行业(%) | 56.29 | -21.21 | -20.55 | -32.33 | 8.09 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 71/219 ， 82/219。
[{"date":"2025-06-30","value":"0.20","vol":"0.21"},{"date":"2025-03-31","value":"0.10","vol":"0.10"},{"date":"2024-12-31","value":"0.40","vol":"0.43"},{"date":"2024-09-30","value":"0.31","vol":"0.33"},{"date":"2024-06-30","value":"0.21","vol":"0.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.20 | 0.10 | 0.40 | 0.31 | 0.21 |
| 行业(次) | 0.21 | 0.10 | 0.43 | 0.33 | 0.23 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.01","vol":"1.31"},{"date":"2025-03-31","value":"0.51","vol":"0.67"},{"date":"2024-12-31","value":"2.20","vol":"3.22"},{"date":"2024-09-30","value":"1.71","vol":"2.18"},{"date":"2024-06-30","value":"1.23","vol":"1.50"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.01 | 0.51 | 2.20 | 1.71 | 1.23 |
| 行业(次) | 1.31 | 0.67 | 3.22 | 2.18 | 1.50 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 40/219 ， 116/219。
[{"date":"2025-06-30","value":"23.96","vol":"2.81"},{"date":"2025-03-31","value":"15.95","vol":"-28.76"},{"date":"2024-12-31","value":"32.87","vol":"-371.46"},{"date":"2024-09-30","value":"33.48","vol":"-9.87"},{"date":"2024-06-30","value":"31.83","vol":"-253.98"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 23.96 | 15.95 | 32.87 | 33.48 | 31.83 |
| 行业 | 2.81 | -28.76 | -371.46 | -9.87 | -253.98 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.95","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.53","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.36","vol":"2.17"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.95 | - | 1.53 | - | 1.36 |
| 行业 | 1.72 | 0.00 | 1.99 | 0.00 | 2.17 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 98/219 ， 68/219。
[{"date":"2025-06-30","value":"3.36","vol":"3.67"},{"date":"2025-03-31","value":"4.23","vol":"3.59"},{"date":"2024-12-31","value":"3.62","vol":"3.34"},{"date":"2024-09-30","value":"3.72","vol":"3.66"},{"date":"2024-06-30","value":"2.70","vol":"3.56"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.36 | 4.23 | 3.62 | 3.72 | 2.70 |
| 行业 | 3.67 | 3.59 | 3.34 | 3.66 | 3.56 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.60","vol":"2.89"},{"date":"2025-03-31","value":"2.33","vol":"2.81"},{"date":"2024-12-31","value":"2.20","vol":"2.64"},{"date":"2024-09-30","value":"2.30","vol":"2.92"},{"date":"2024-06-30","value":"1.73","vol":"2.86"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.60 | 2.33 | 2.20 | 2.30 | 1.73 |
| 行业 | 2.89 | 2.81 | 2.64 | 2.92 | 2.86 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 109/219 ， 109/219。
[{"date":"2025-06-30","value":"18.13","vol":"33.79"},{"date":"2025-03-31","value":"15.98","vol":"34.04"},{"date":"2024-12-31","value":"16.37","vol":"34.19"},{"date":"2024-09-30","value":"15.52","vol":"33.02"},{"date":"2024-06-30","value":"18.35","vol":"32.96"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
18.13 | 15.98 | 16.37 | 15.52 | 18.35 |
| 行业(%) | 33.79 | 34.04 | 34.19 | 33.02 | 32.96 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.23","vol":"0.88"},{"date":"2025-03-31","value":"0.19","vol":"1.46"},{"date":"2024-12-31","value":"0.20","vol":"0.84"},{"date":"2024-09-30","value":"0.18","vol":"0.73"},{"date":"2024-06-30","value":"0.23","vol":"0.70"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.23 | 0.19 | 0.20 | 0.18 | 0.23 |
| 行业(%) | 0.88 | 1.46 | 0.84 | 0.73 | 0.70 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 财信证券 | 2025-09-26 | 增持 | |
| 天风证券 | 2025-09-15 | 买入 | |
| 中信证券 | 2025-09-08 | 买入 | |
| 中信建投证券 | 2025-09-02 | 买入 | |
| 东方证券 | 2025-09-01 | 增持 | |
| 野村东方国际证券 | 2025-08-28 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"5.34","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"6.37","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.80","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"6.02","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"6.95","blueLineValue":"0.62","type":"YC"}]